- Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon
- Author: Mr Mfazo Hove
- Published: September 6, 2024
- Last Updated: September 22, 2026
TL;DR: YAG laser capsulotomy side effects are usually mild and temporary, including floaters, brief blur, light sensitivity or minor discomfort. Recognised YAG laser capsulotomy risks include raised eye pressure, marks on the artificial lens, swelling in the central retina and, rarely, a retinal tear or detachment.
Understanding YAG Laser Capsulotomy Side Effects
YAG laser capsulotomy has a long safety record, and most patients experience only mild, temporary effects.¹ Understanding both the common sensations and the rarer risks supports informed consent.
Common YAG Laser Capsulotomy Side Effects
- Capsule-related floaters: Patients may notice small moving specks caused by tiny fragments from the treated lens capsule. These often become less noticeable over days to weeks.¹
- Pre-existing vitreous floaters: Patients may become more aware of existing floaters once the visual axis, the central pathway through which light enters the eye, is clearer. These floaters are caused by small clumps within the vitreous, the gel that fills the eye, and may remain.
- Mild discomfort or grittiness: This may arise from the contact lens, drops or ocular surface, meaning the front surface of the eye. It typically settles within 24–48 hours.¹
- Temporary blurred vision and light sensitivity: These effects are often related to the dilating drops.¹
Recognised YAG Laser Capsulotomy Risks
- Raised intraocular pressure: The pressure inside the eye can rise during the first few hours. This is usually temporary and can be managed with topical medication, meaning eye drops, when required. Pressure is checked routinely before the procedure and after treatment if indicated.¹ ²
- Intraocular lens pitting: Small marks can occur on the artificial lens if the laser is focused slightly too far forward. Most marks do not affect vision, although centrally placed damage can occasionally affect visual quality.²
- Cystoid macular oedema: This is swelling in the macula, the central part of the retina responsible for detailed vision. It is uncommon and more likely in eyes with pre-existing risk factors.¹ ²
- Retinal tear or detachment: This is rare. Large outcome studies have reported an increased risk of retinal complications after capsulotomy.² ³
- Anterior chamber inflammation: Mild, short-lived inflammation can occur in the front part of the eye.¹ ²
The likelihood of retinal complications is also influenced by factors relating to the eye itself. These include having a pseudophakic eye, meaning an eye containing an artificial lens, a longer axial length from the front to the back of the eye, and pre-existing vitreoretinal pathology affecting the vitreous gel or retina.² ³
How Blue Fin Vision® Manages Risk
Every patient undergoes macular optical coherence tomography (OCT) before the laser. This detailed scan of the central retina can identify macular disease that may be contributing to the symptoms, limiting the expected improvement or influencing the timing and aftercare of treatment.
Macular OCT does not replace clinical examination of the lens capsule or, where indicated, a dilated assessment of the peripheral retina.
The lowest effective energy settings and an appropriate laser offset are used. Laser offset means adjusting the point of focus in relation to the capsule to improve treatment precision.
Thorough assessment improves patient selection but cannot eliminate inherent risk.
YAG Laser Capsulotomy Aftercare
Do not drive yourself home after treatment because the dilating drops can temporarily blur your vision. Arrange suitable alternative transport.⁴
Resume driving only when the dilation has worn off, your vision has stabilised and you meet the Driver and Vehicle Licensing Agency (DVLA) legal eyesight requirements.⁵
Most patients resume ordinary activities on the same day or the following day.⁴
When to Contact Blue Fin Vision® Urgently
Contact the clinical team urgently if you experience any of the following:⁴
- A significant increase in pain
- Increasing redness
- Worsening vision
- A sudden shower of floaters
- New flashes of light
- A curtain or shadow in your vision
Making an Informed Decision
YAG laser capsulotomy is generally well tolerated. Side effects are usually mild and temporary, and serious complications are uncommon.¹
A careful pre-laser assessment helps ensure the procedure is appropriate and sets realistic expectations.
Discuss YAG Laser Capsulotomy with Blue Fin Vision®
Book a paid, consultant-led consultation with Blue Fin Vision® in London, Hertfordshire or Essex to discuss YAG laser capsulotomy risks, your suitability for treatment and any concerns about side effects.
References
- Karahan E, Er D, Kaynak S. An overview of Nd:YAG laser capsulotomy. Med Hypothesis Discov Innov Ophthalmol. 2014;3(2):45-50.
- Aslam TM, Devlin H, Dhillon B. Use of Nd:YAG laser capsulotomy. Surv Ophthalmol. 2003;48(6):594-612.
- Javitt JC, Tielsch JM, Canner JK, Kolb MM, Sommer A, Steinberg EP; Cataract Patient Outcomes Research Team. National outcomes of cataract extraction. Increased risk of retinal complications associated with Nd:YAG laser capsulotomy. Ophthalmology. 1992;99(10):1487-1498.
- Moorfields Eye Hospital NHS Foundation Trust. YAG laser treatment for posterior capsule opacification (PCO) [Internet]. London: Moorfields Eye Hospital NHS Foundation Trust; 2019 [cited 2026 Sep 11]. Available from: https://www.moorfields.nhs.uk/mediaLocal/adiigm1v/yag-laser-treatment-for-posterior-capsule-opacification-pco.pdf
- Driver and Vehicle Licensing Agency. Driving eyesight rules [Internet]. GOV.UK [cited 2026 Sep 11]. Available from: https://www.gov.uk/driving-eyesight-rules
ABOUT THE AUTHOR
Mr Mfazo Hove
Consultant Ophthalmic Surgeon
MBChB MD FRCOphth CertLRS
Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with experience spanning more than 57,000 procedures. He completed 6.5 years of specialist training at Moorfields Eye Hospital and served for five years as a consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust. He is the founder of Blue Fin Vision®, a consultant-led private ophthalmology practice operating across London, Essex, and Hertfordshire. His clinical expertise encompasses advanced cataract surgery, refractive lens replacement, laser vision correction, and implantable Collamer lenses (ICL).
A ZEISS Key Opinion Leader, Mr Hove is a respected international speaker with five invited engagements across seven cities in 2026:
- ZEISS China tour (Changsha, Shanghai, and Hangzhou, April – ZEISS APAC User Meeting)
- RCOphth Annual Congress – May – Manchester
- ZEISS EMEA User Meeting (Istanbul)
- ZEISS Lausanne User Meeting (Lausanne)
- European Society of Cataract and Refractive Surgeons Annual Congress (ESCRS, London)
